TICKERNOMICS Sign up
Last Update: 2024-03-28 02:15:57
Cardio Diagnostics Holdings Inc. ( CDIO ) https://cardiodiagnosticsinc.com
1.35USD
Sector:
Healthcare
Industry:
Biotechnology
Country:
United States
1y
3y
5y
10y
Historical Returns*:
SPY
31.15%
-65.30%
CDIO
SPY
32.74%
CDIO
0.00%
SPY
92.93%
CDIO
0.00%
SPY
224.41%
CDIO
0.00%
*Assumes dividends reinvested
Market Stats:
Market Capitalization($MM)
Enterprise Value($MM)
Daily Volume(MM)
27.57
24.84
0.20
Valuation Metrics:
Price/Earnings Ratio
Price/Sales Ratio
Price/Book Value
FCF Yield(%)
Dividend Yield(%)
EV/EBITDA
-2.94
2169.85
12.05
-21.11
0.00
-3.49
Profitability Stats:
Operating Margin %(ttm)
Gross Profit %(ttm)
EBITDA Margin %(ttm)
-14398.71
0.00
-22395.88
Shareholder Value Creation:
Cost of Capital %(est)
ROIC %(ttm)
ROCE %(ttm)
Beta
4.27
-676.24
-137.40
0.00
Other Earnings and Cash Flow Stats:
Cardio Diagnostics Holdings Inc. ( CDIO ) Net Income TTM ($MM) is -6.49
Cardio Diagnostics Holdings Inc. ( CDIO ) Operating Income TTM ($MM) is -6.68
Cardio Diagnostics Holdings Inc. ( CDIO ) Owners' Earnings Annual ($MM) is 0.00
Cardio Diagnostics Holdings Inc. ( CDIO ) Current Price to Owners' Earnings ratio is 0.00
Cardio Diagnostics Holdings Inc. ( CDIO ) EBITDA TTM ($MM) is -6.66
Cardio Diagnostics Holdings Inc. ( CDIO ) EBITDA Margin is -22395.88%
Capital Allocation:
Cardio Diagnostics Holdings Inc. ( CDIO ) has paid 0.00 dividends per share and bought back -15.665995 million shares in the past 12 months
Cardio Diagnostics Holdings Inc. ( CDIO ) has increased its debt by 0.0 million USD in the last 12 months
Capital Structure:
Cardio Diagnostics Holdings Inc. ( CDIO ) Interest-bearing Debt ($MM) as of last quarter is 0
Cardio Diagnostics Holdings Inc. ( CDIO ) Annual Working Capital Investments ($MM) are 0
Cardio Diagnostics Holdings Inc. ( CDIO ) Book Value ($MM) as of last quarter is 2
Cardio Diagnostics Holdings Inc. ( CDIO ) Debt/Capital as of last quarter is 39%
Other Balance Sheet Stats:
Cardio Diagnostics Holdings Inc. ( CDIO ) has 3 million in cash on hand as of last quarter
Cardio Diagnostics Holdings Inc. ( CDIO ) has 2 million of liabilities due within 12 months, and long term debt 0 as of last quarter
Cardio Diagnostics Holdings Inc. ( CDIO ) has 18 common shares outstanding as of last quarter
Cardio Diagnostics Holdings Inc. ( CDIO ) has 0 million USD of preferred stock value
Academic Scores:
Cardio Diagnostics Holdings Inc. ( CDIO ) Altman Z-Score is -2.18 as of last quarter
Cardio Diagnostics Holdings Inc. ( CDIO ) Piotroski Score is 1.00 as of last quarter
Corporate Governance:
Cardio Diagnostics Holdings Inc. ( CDIO ) largest shareholder is owning shares at 0.00 ($MM) value
Meeshanthini Dogan(an insider) Bought 16481 shares of Cardio Diagnostics Holdings Inc. ( CDIO ) for the amount of $9064.55 on 2023-08-31
35.80% of Cardio Diagnostics Holdings Inc. ( CDIO ) is held by insiders, and 3.36% is held by institutions
Cardio Diagnostics Holdings Inc. ( CDIO ) went public on 2022-01-14
Other Cardio Diagnostics Holdings Inc. ( CDIO ) financial metrics:
FCF:-7.43
Unlevered Free Cash Flow:-28.03
EPS:-0.41
Operating Margin:-14398.71
Gross Profit Margin:0.00
Div. Payout Ratio%:0.00
Div. Growth YoY%:0.00
Equity Return%:-337.87
Beta:0.00
Buffet's Owners Earnings:0.00
Price to Owner's Earnings:0.00
About Cardio Diagnostics Holdings Inc. ( CDIO ) :
Cardio Diagnostics Holdings, Inc., an artificial intelligence-powered precision cardiovascular medicine company, develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease. The company was founded in 2017 and is headquartered in Chicago, Illinois.
User Content from Tickernomics. Created by Luminus.
DISCLAIMER

This web site and its creators are not certified financial advisors. All opinions/suggestions expressed on this website should not be treated as specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion.The Company doesn't warrant the information provided on the website for its completeness or accuracy, and it should not be relied upon as such. The Company is not under any obligation to update or correct any information provided on this website.The content of this website is published in the United States of America and persons who access it agree to do so in accordance with applicable U.S. law.Past performance is not indicative of future results. The Company doesn't guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed on this website.Strategies or investments discussed may fluctuate in price or value. Investors may get back less than invested. Investments or strategies mentioned on this website may not be suitable for you. This material does not take into account your particular investment objectives,financial situation or needs and is not intended as recommendations appropriate for you. You must make an independent decision regarding investments or strategies mentioned on this website. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.